The United Nations Office at Geneva
Multimedia Newsroom
STORYLINE
Injectable HIV medicines deal to provide access to generic lifesaver in developing nations
A landmark agreement has been reached allowing for the production of low-cost, injectable HIV medicines in some 90 developing countries where more the majority of infections occur, UNITAID said on Friday.
Selected manufacturers will be able to develop, manufacture and supply lower-cost generic versions of long-acting Cabotegravir (CAB-LA), in line with a deal reached with pharmaceutical firm ViiV Healthcare (ViiV).
“The Medicines Patent Pool, a structure created and largely funded by UNITAID, has reached a voluntary licensing agreement for patents relating to Cabotegravir long-acting, an injectable form of HIV prevention, or PrEP, to generic formulations of the product in least-developed, low-income, lower-middle income and sub-Saharan African countries,” said UNITAID spokesperson Hervé Verhoosel.
The deal is significant because Cabotegravir injections are only needed once every few months. Increasing its supply at a cost that is affordable to low-income countries could help to overcome the stigma that’s associated with taking daily HIV pills - and the burden of having to remember to take them.
“In the 90 countries that we are talking about, 80 countries are royalty-free, meaning that ViiV won’t ask for any royalty on the product and for 10 of those countries, ViiV is asking for a smaller-than-usual royalty,” Mr. Verhoosel explained.
The agreement comes after UNITAID-led discussions began in May this year with ViiV, a subsidiary of pharma giant GlaxoSmithkline. It is only seven months since Cabotegravir LA received regulatory approval.
But the process of selecting the companies that will develop, manufacture and supply generic versions of Cabotegravir will take much longer.
“This product will not be there for everybody, that’s first for people who are there the most at risk,” said Mr. Verhoosel, who noted that the cost of the medicine in the US when it comes onstream there “really soon”, was likely to be around $20,000. “That’s a lot of money; that’s why that product cannot be used in low and middle-income countries.”
According to UNITAID, the deal offers the possibility of making the injectable prophylactic medicine available in 90 countries where more than 70 per cent of all new HIV infections occurred in 2020.
Up to three drug manufacturers will be licensed to develop the product on a generic basis to avoid supply and distribution issues. “That’s done in a way that we’re sure (that) one, it’s easy for logistics, two…availability, and three, of course, that it will help to bring the cost of the generic version down”, said Mr. Verhoosel.
ends
STORY: Injectable HIV Prevention Medicines Deal - UNITAID
TRT: 02’05”
SOURCE: UNTV CH
RESTRICTIONS: NONE
LANGUAGE: ENGLISH/NATS
ASPECT RATIO: 16:9
DATELINE: Friday 29 July 2022, GENEVA, SWITZERLAND
SHOTLIST
- Medium shot, UN Geneva flag alley.
- Wide shot, press room with panel of speakers, journalists, TV camera on tripod.
- SOUNDBITE (ENGLISH) Hervé Verhoosel, UNITAID: “The Medicines Patent Pool, a structure created and largely funded by UNITAID, has reached a voluntary licensing agreement for patents relating to cabotegravir long-acting, an injectable form of HIV prevention, or PrEP, to generic formulations of the product in least-developed, low-income, lower-middle income and sub-Saharan African countries.”
- Medium shot, lateral, podium speakers.
- SOUNDBITE (ENGLISH) Hervé Verhoosel, UNITAID: “In the 90 countries that we are talking about, 80 countries are royalty-free, meaning that ViiV (ViiV Healthcare) don’t ask any royalty on the product and for 10 of those countries ViiV is asking for a smaller-than-usual royalty.”
- Wide shot, journalists, TV camera, light panel.
- SOUNDBITE (ENGLISH) Hervé Verhoosel, UNITAID: “This product will not be there for everybody, that’s first for people who are there the most at risk. That’s a product that’s available in the US, and the price of that product for one year in the US for example is approximately 20,000 US dollars, and that’s a lot of money; that’s why that product cannot be used in low and middle-income countries.”
- Medium shot, journalists seated at tables, TV camera.
- SOUNDBITE (ENGLISH) Hervé Verhoosel, UNITAID: “This licence will actually give the option to three different generic manufacturers to develop the product on a generic base. That means that the price that those companies will have we don’t know yet, but that will not only be one company, that will be three different companies and that’s done in a way that we’re sure one, that it’s easy for logistics, two, that ensuring availability, and three, of course, that it will help to bring the cost of the generic version down.”
- Medium shot, journalists.
- Wide shot, journalists, TV camera and light panel.
- Medium shot, journalist.
- Medium shot, journalists, side shot.
Similar Stories
1
1
1
Edited News | OCHA , UNHCR , WHO
The past two months of intensifying Israeli bombardment in Lebanon have been the “deadliest and most devastating” in decades as communities uprooted from the front line have continued to flee across the border to Syria, UN humanitarians said on Friday.
2
1
3
Edited News | UNOG
“State of Silence”: Diego Luna brings the fight to protect the press to the UN in Geneva
Mexican actor, producer and director Diego Luna has brought his fight to protect journalists all the way to the United Nations, in Geneva. Together with documentary director Santiago Masa, he is putting a spotlight on the silencing of investigative journalism in his country, and on the incredibly high price that many journalist have to pay in pursuit of truth.
1
1
1
Edited News | OHCHR , UNOG
“Today marks the grim milestone of 1,000 days since the Russian Federation launched its full-scale armed attack on Ukraine. Our Office has verified that at least 12,162 civilians have been killed since 24 February 2022, among them 659 children. At least another 26,919 civilians have been injured,” UN Human Rights spokesperson Jeremy Laurance told the bi-weekly press briefing in Geneva.
1
1
1
Edited News | OHCHR , UNOG
With COP29 in Baku now in its second - and final - week, UN Human Rights Chief Volker Türk has reiterated his call for urgent human rights-based climate action.
1
1
1
Edited News | UNIFIL , UNICEF , WHO
Lebanon: Increased violence along Blue Line and ‘horrific new normal’ for children
In southern Lebanon, peacekeepers have witnessed “shocking” destruction of villages along the Blue Line and ever-deeper Israeli ground incursions, while the situation of children across the country is becoming increasingly desperate, the UN said on Tuesday.
2
1
2
Press Conferences , Edited News | UNRWA
The head of the UN agency for Palestine refugees, UNRWA, confirmed on Monday that a large convoy of humanitarian aid was looted inside Gaza at the weekend, amid a near-total a breakdown in law and order and harassment of the agency’s staff by Israeli soldiers.
1
1
1
Edited News | OCHA
In the nearly 1,000 days since Russia’s full-scale invasion of Ukraine, thousands of civilians have been killed, the country’s energy infrastructure is on the brink and drones terrify communities on the front line, the UN’s top aid official in the country said on Friday.
2
1
2
Press Conferences , Edited News | OHCHR
Mexican actor, producer and director Diego Luna took a break from the big screen on Thursday to highlight the dangers faced by journalists in his country and beyond, condemning murders of reporters everywhere as “a scandal”.
1
1
1
Edited News | UNRWA
Gaza: ‘People are losing hope’ as aid access is refused to north, warns UNRWA
Besieged northern Gaza is a place of dead bodies lying in the streets and hospitals running out of blood packs – a situation that’s “nothing short of catastrophic”, the UN agency for Palestinian refugees (UNRWA) said on Tuesday.
1
1
1
Edited News | OHCHR
UN Human Rights Spokesperson Jeremy Laurence & Ajith Sunghay, Head of UN Human Rights Office in the Occupied Palestinian Territory, on Gaza
1
1
1
Edited News | UNHCR
Sudan’s displaced have endured “unimaginable suffering” in their search for shelter from the country’s ongoing war, UN humanitarians warned on Friday.
1
1
1
Edited News | WHO
‘Exceptional achievement’: Humanitarians reach over 105,000 with polio vaccine in north Gaza
Despite ongoing attacks and access challenges, humanitarians have managed to inoculate over 105,000 children in north Gaza with the second and final dose of the oral polio vaccine, the UN World Health Organization (WHO) said on Tuesday.